Provider
P4-17 Addition of Drug to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Jan 30, 2017
Documents & Forms Results
Displaying 2701 - 2710 of 3563 results
Provider
P47-16 New Drug-Related Prior Authorization Requirements for Botulinum Toxin, Remicade, Rituxan and Biologic Immunomodulators
Program effective Date: Oct 10, 2016
Provider
P56-17 Implementation of a Medical Drug Exclusions List
Program effective Date: Oct 16, 2017
Provider
P5R1-17 Updated: Third Party Payments of Premium and/or Cost-Sharing
Program effective Date: Jul 05, 2017
Provider
P50-16 Addition of a Drug (Xiidra) to the Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program
Program effective Date: Oct 28, 2016
Provider
P53-16 New Notification Requirement for Outpatient Dialysis Services for Commercial Products and Subscribers in Government Programs
Program effective Date: Nov 09, 2016
Provider
P43R1-16 Updated: Third Party Payments of Premium and/or Cost-Sharing
Program effective Date: Nov 01, 2016
Provider
P6-17 A New Drug, Emflaza (deflazacort), Will Require Prior Authorization
Program effective Date: Feb 27, 2017
Provider
P46-16 Changes in Medical Policy IV-87 Spinal Fusion: Lumbar
Program effective Date: Sep 30, 2016
Provider
P17-17 Addition of Drug Kisqali to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Apr 28, 2017